2. URL: https://iris.who.int/bitstream/handle/10665/374877/9789240084810-eng.pdf?sequence=1

3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86. Doi: 10.1056/NEJM199309303291401.

4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–53.

5. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова.11-е изд. М., 2023.

6. Danne T., Nimri R., Battelino T., et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017;40:1631–40. Doi: 10.2337/dc17-1600.

7. Gagliardino J.J., Chantelot J.M., Domenger C., et al. Impact of diabetes education and self-management on the quality of care for people with type 1 diabetes mellitus in the Middle East (the International Diabetes Mellitus Practices Study, IDMPS). Diabetes Res Clin Pract. 2019;9(147):29–36. Doi: 10.1016/j.diabres.2018.09.008.

8. Grady M., Katz L.B., Cameron H., Levy B.L. Diabetes app-related text messages from health care professionals in conjunction with a new wireless glucose meter with a color range indicator improves glycemic control in patients with type 1 and type 2 diabetes: randomized controlled trial. JMIR Diabetes. 2017;2(2):e19 Doi:10.2196/diabetes.7454.

9. Danne T., Nimri R., Battelino T., et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017;40:1631–40. Doi: 10.2337/dc17-1600.

10. Beck R. W., Bergenstal R.M., Cheng P., et al. The relationships between time in range, hyperglycemia metrics, and HbA1c. J Diabetes Sci Technol. 2019;13(4):614–26. Doi: 10.1177/1932296818822496.

11. Lu J., Ma X, Zhou J., et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes. Diabetes Care. 2018;41(11):2370–76. Doi:10.2337/dc18-1131.

12. Lu J., Home P.D., Zhou J. Comparison of multiple cut points for time in range in relation to risk of abnormal carotid intima-media thickness and diabetic retinopathy. Diabetes Care. 2020;43:e99–e101. Doi: 10.2337/dc20-0561.

13. Yoo J.H., Kim J.H. Time in range from continuous glucose monitoring: a novel metric for glycemic control. Diabetes Metab J. 2020;44(6):828–39. Doi:10.4093/dmj.2020.0257.

14. Ranjan A.G., Rosenlund S.V., Hansen T.W., et al. Improved time in range over 1 year is associated with reduced albuminuria in individuals with sensor-augmented insulin pump-treated type 1 diabetes. Diabetes Care. 2020;43(11):2882–2885. Doi: 10.2337/dc20-0909.

15. Yang J., Yang X., Zhao D., et al. Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy. J Diabetes Investig. 2021;12(5):828–36. Doi: 10.1111/jdi.13394.

16. Lu J., Wang C., Shen Y., et al. Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study. Diabetes Care. 2021;44(2):549–55. Doi: 10.2337/dc20-1862.

17. Steinhubl S.R, Muse E.D., Topol E.J. Can mobile health technologies transform health care? JAMA. 2013;310(22):2395–96. Doi: 10.1001/jama.2013.281078.

18. Garabedian L.F, Ross-Degnan D., Wharam J.F. Mobile phone and smartphone technologies for diabetes care and self-management. Curr Diab Rep. 2015;15(12):109. Doi: 10.1007/s11892-015-0680-8.

19. Vaala S.E., Hood K.K., Laffel L., et al. Use of commonly available technologies for diabetes information and self-management among adolescents with type 1 diabetes and their parents: a web-based survey study. Interact J Med Res. 2015;4(4):e24. Doi: 10.2196/ijmr.4504.

20. Liang X., Wang Q., Yang X., et al. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med. 2011;28(4):455–63. Doi: 10.1111/j.1464-5491.2010.03180.x.

21. Arambepola C., Ricci-Cabello I., Manikavasagam P., et al. The impact of automated brief messages promoting lifestyle changes delivered via mobile devices to people with type 2 diabetes: a systematic literature review and meta-analysis of controlled trials. J Med Internet Res. 2016;18(4):e86. Doi: 10.2196/jmir.5425.

22. Hsu W.C., Lau K.H.K., Huang R., et al. Utilization of a cloud-based diabetes management program for insulin initiation and titration enables collaborative decision making between healthcare providers and patients. Diabetes Technol Ther. 2016;18(2):59-67. Doi: 10.1089/dia.2015.0160.

23. Grady M., Cameron H., Holt Е. Sustained improvements in readings in-range using an advanced bluetooth® connected blood glucose meter and a mobile diabetes app: real-world evidence from more than 55,000 people with diabetes. Diabetes Ther. 2023;14(6):1023–35. Doi: 10.1007/s13300-023-01415-3.

24. Poster presented at Diabetes Technology Meeting (DTM) 2018; North Bethesda, Maryland Poster presented at Diabetes Technology Meeting (DTM) 2018; North Bethesda, Maryland.